CLIRLIVIE Trademark

Trademark Overview

On Monday, December 2, 2024, a trademark application was filed for CLIRLIVIE with the United States Patent and Trademark Office. The USPTO has given the CLIRLIVIE trademark a serial number of 98881013. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, December 2, 2024. This trademark is owned by Corcept Therapeutics Incorporated. The CLIRLIVIE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders
clirlivie

General Information

Serial Number98881013
Word MarkCLIRLIVIE
Filing DateMonday, December 2, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, December 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing0 - NOT AVAILABLE
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the literal element Clirlivie in stylized lettering with a right-facing caret to the left and a diamond with three rounded corners nestled within the caret. A negative space line connects the right-facing caret and the C of Clirlivie..
Goods and ServicesPharmaceutical preparations for the treatment of endocrine diseases and disorders; pharmaceutical preparations for the treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations for the treatment of Cushing's syndrome and Cushing's disease; pharmaceutical preparations for the treatment of cancer, liver disorders, oncologic, endocrine, metabolic, cardiovascular, ophthalmic, and gastroenterologic diseases and disorders
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCorcept Therapeutics Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMenlo Park, CA 94025

Trademark Events

Event DateEvent Description
Monday, December 2, 2024NEW APPLICATION ENTERED

Related Keywords

clirlivie pharmaceutical disorders treatment preparations diseases cushing endocrine metabolic cardiovascular ophthalmic